Nuvalent Stock Gross Profit
| NUVL Stock | USD 96.76 0.46 0.48% |
Nuvalent fundamentals help investors to digest information that contributes to Nuvalent's financial success or failures. It also enables traders to predict the movement of Nuvalent Stock. The fundamental analysis module provides a way to measure Nuvalent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nuvalent stock.
Nuvalent | Gross Profit |
Nuvalent Company Gross Profit Analysis
Nuvalent's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Nuvalent Gross Profit Driver Correlations
Understanding the fundamental principles of building solid financial models for Nuvalent is extremely important. It helps to project a fair market value of Nuvalent Stock properly, considering its historical fundamentals such as Gross Profit. Since Nuvalent's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nuvalent's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nuvalent's interrelated accounts and indicators.
Click cells to compare fundamentals
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Nuvalent reported 0.0 of gross profit. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
Nuvalent Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nuvalent's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nuvalent could also be used in its relative valuation, which is a method of valuing Nuvalent by comparing valuation metrics of similar companies.Nuvalent is currently under evaluation in gross profit category among its peers.
Nuvalent ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nuvalent's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nuvalent's managers, analysts, and investors.Environmental | Governance | Social |
Nuvalent Fundamentals
| Return On Equity | -0.3 | ||||
| Return On Asset | -0.19 | ||||
| Current Valuation | 5.67 B | ||||
| Shares Outstanding | 65.62 M | ||||
| Shares Owned By Insiders | 2.83 % | ||||
| Shares Owned By Institutions | 97.17 % | ||||
| Number Of Shares Shorted | 4.9 M | ||||
| Price To Earning | (0.06) X | ||||
| Price To Book | 6.10 X | ||||
| EBITDA | (149.49 M) | ||||
| Net Income | (126.22 M) | ||||
| Cash And Equivalents | 256.96 M | ||||
| Cash Per Share | 5.31 X | ||||
| Total Debt | 31.82 M | ||||
| Debt To Equity | 2.81 % | ||||
| Current Ratio | 25.79 X | ||||
| Book Value Per Share | 15.81 X | ||||
| Cash Flow From Operations | (99.74 M) | ||||
| Short Ratio | 10.33 X | ||||
| Earnings Per Share | (3.49) X | ||||
| Target Price | 115.5 | ||||
| Number Of Employees | 127 | ||||
| Beta | 1.33 | ||||
| Market Capitalization | 6.88 B | ||||
| Total Asset | 732.38 M | ||||
| Retained Earnings | (286.3 M) | ||||
| Working Capital | 694.66 M | ||||
| Current Liabilities | 5.46 M | ||||
| Net Asset | 732.38 M |
About Nuvalent Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nuvalent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nuvalent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nuvalent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Nuvalent Piotroski F Score and Nuvalent Altman Z Score analysis. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.49) | Return On Assets (0.19) | Return On Equity (0.30) |
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.